Evolving Trends in Practice Patterns of North American Vitreoretinal Surgery Fellows From 2010-2016

Related

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018

• 

  My Practice is Worth WHAT? Equity Acquisition in the Retina World

  Robert L. Avery, MD

  Carl W. Baker, MD, FASRS

  Michael S. Jacobson, MD

  Reginald J. Sanders, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Heads-Free!: 3D Head-Mounted Display System for Vitreoretinal Surgery

  Murat Oncel, MD, FASRS

  Annual Meeting Talks

  2018